Author: Cheng, Li; Yang, Jian-Zhong; Bai, Wen-Hui; Li, Zhuan-Yun; Sun, Li-Fang; Yan, Juan-Juan; Zhou, Chen-Liang; Tang, Bao-Peng
Title: Prognostic value of serum amyloid A in patients with COVID-19 Cord-id: cz4twupu Document date: 2020_7_30
ID: cz4twupu
Snippet: OBJECTIVE: To investigate the prognostic value of serum amyloid A (SAA) in the patients with Corona Virus Disease 2019 (COVID-19). METHODS: The medical data of 89 COVID-19 patients admitted to Renmin Hospital of Wuhan University from January 3, 2020 to February 26, 2020 were collected. Eighty-nine cases were divided into survival group (53 cases) and non-survival group (36 cases) according to the results of 28-day follow-up. The SAA levels of all patients were recorded and compared on 1 day afte
Document: OBJECTIVE: To investigate the prognostic value of serum amyloid A (SAA) in the patients with Corona Virus Disease 2019 (COVID-19). METHODS: The medical data of 89 COVID-19 patients admitted to Renmin Hospital of Wuhan University from January 3, 2020 to February 26, 2020 were collected. Eighty-nine cases were divided into survival group (53 cases) and non-survival group (36 cases) according to the results of 28-day follow-up. The SAA levels of all patients were recorded and compared on 1 day after admission (before treatment) and 3 days, 5 days, and 7 days after treatment. The ROC curve was drawn to analyze the prognosis of patients with COVID-19 by SAA. RESULTS: The difference of comparison of SAA between survival group and non-survival group before treatment was not statistically significant, Z(1) = − 1.426, P = 0.154. The Z(1) values (Z(1) is the Z value of the rank sum test) of the two groups of patients at 3 days, 5 days, and 7 days after treatment were − 5.569, − 6.967, and − 7.542, respectively. The P values were all less than 0.001, and the difference was statistically significant. The ROC curve results showed that SAA has higher sensitivity to the prognostic value of 1 day (before treatment), 3 days, 5 days, and 7 days after treatment, with values of 0.806, 0.972, 0.861, and 0.961, respectively. Compared with SAA on the 7th day and C-reactive protein, leukocyte count, neutrophil count, lymphocyte count, and hemoglobin on the 7th day, the sensitivities were: 96.1%, 83.3%, 88.3%, 83.3%, 67.9%, and 83.0%, respectively, of which SAA has the highest sensitivity. CONCLUSION: SAA can be used as a predictor of the prognosis in patients with COVID-19.
Search related documents:
Co phrase search for related documents- abnormal coagulation and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- abnormal coagulation and acute stage: 1
- abnormal coagulation and liver kidney: 1, 2, 3, 4, 5
- abnormal coagulation and logistic regression: 1, 2, 3, 4
- abnormal coagulation function and acute respiratory syndrome: 1, 2
- abnormal coagulation function and liver kidney: 1, 2
- abnormal coagulation function and logistic regression: 1
- abroad home and acute respiratory syndrome: 1
- abroad home and logistic regression: 1
- absolute count and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
- absolute count and acute phase protein: 1, 2, 3, 4, 5
- absolute count and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- absolute count and admission day: 1, 2, 3, 4, 5
- absolute count and liver kidney: 1, 2
- absolute count and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- activity value and acute phase: 1
- activity value and acute phase protein: 1
- activity value and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
- activity value and logistic regression: 1
Co phrase search for related documents, hyperlinks ordered by date